Based on years of scientific laboratory and clinical research a model has been developed for optimizing neurotransmitter levels in order to determine many conditions. It maximizes health and well being by targeting amino acids to balance neurotransmitter synergy.
The balance of neurotransmitter levels can facilitate or hamper the well-being and have a direct impact on the efficacy of treatments thus the importance of laboratory data. Laboratory data in conjunction with clinical findings demonstrate that many common symptoms are influenced by neurotransmitters. Correcting these levels with neurotransmitter precursors improves the many symptoms.
Testing provides a baseline and establishes levels of up to thirteen neurotransmitters and provides a reference point for therapy. Profiles include urinary neurotransmitters and salivary hormone testing. Baseline testing is performed because:
Symptoms alone do not identify an imbalance
Provides guidance for the therapeutic analysis
Provides a reference point for monitoring therapy
Continuation of the monitoring provides indication to the practitioner for adjustment of patient dosages. Upon completion of the test profiles a “profile summary” is provided.
This testing can identify one or more biochemical imbalances that may be playing a role in the various conditions.
1 – 2 Weeks
Addresses transmitter levels
Balances the levels
of neurotransmitters. This can
last between 3-6 months.
Continuation of Therapy
Continuation of therapy
phase, maintenance and